Fig. 3: Examples for patient-specific sets of active unbalanced processes.

Each patient typically harbors a set of 1–3 active unbalanced processes. Our results show that a specific set of active processes does not necessarily distinguish between BRAFV600E− and BRAFV600E+ patients, or between SKCM and THCA patients.